Endolymphatic infusion: human surgical investigation and application

Area of Science:

• Lymphatic system research
• Surgical interventions
• Pharmacology

Background:

• The lymphatic system plays a crucial role in disease processes.
• Therapeutic manipulation of lymph composition and flow can impact disease outcomes.
• Targeting lymphatic infections requires specialized approaches.

Purpose of the Study:

• To investigate the use of endolymphatic infusion (ELI) of drugs for therapeutic purposes.
• To evaluate the impact of ELI on lymphatic vessel activity and lymph flow.
• To assess the clinical efficacy of ELI in a large patient cohort.

Main Methods:

• Experimental studies on the effects of various antibiotics on lymphatic contractile activity and lymph flow.
• Application of endolymphatic infusion (ELI) in a surgical context.
• Clinical evaluation of ELI in 330 patients with protocols designed to modify lymph flow.

Main Results:

• Antibiotics were shown to temporarily decrease lymphatic vessel contractility and reduce lymph flow volume.
• Endolymphatic infusion (ELI) was successfully applied in a clinical setting.
• Protocols utilizing ELI were employed to alter lymph flow characteristics in patients.

Conclusions:

• Endolymphatic infusion (ELI) is a viable surgical approach for targeting the lymphatic system.
• Modulating lymphatic system characteristics through ELI may offer therapeutic benefits.
• Further research into ELI applications for disease intervention is warranted.